A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
Khorana AA, Rosenblatt JD, Sahasrabudhe DM, Evans T, Ladrigan M, Marquis D, Rosell K, Whiteside T, Phillippe S, Acres B, Slos P, Squiban P, Ross M, Kendra K.
Khorana AA, et al. Among authors: rosenblatt jd.
Cancer Gene Ther. 2003 Apr;10(4):251-9. doi: 10.1038/sj.cgt.7700568.
Cancer Gene Ther. 2003.
PMID: 12679797
Clinical Trial.